CytoDyn Inc. Stock Other OTC
Equities
CYDY
US23283M1018
Biotechnology & Medical Research
Sales 2022 | 0.27 0.36 | Sales 2023 | - | Capitalization | 239M 328M |
---|---|---|---|---|---|
Net income 2022 | -211M -289M | Net income 2023 | -79M -108M | EV / Sales 2022 | 989,524,989 x |
Net Debt 2022 | 32.57M 44.56M | Net Debt 2023 | 33.01M 45.17M | EV / Sales 2023 | - |
P/E ratio 2022 |
-1.02
x | P/E ratio 2023 |
-2.52
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 99.15% |
Latest transcript on CytoDyn Inc.
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 64 | 11-16 | |
Mitchell Cohen
DFI | Director of Finance/CFO | 68 | 01-31 |
Scott Hansen
CTO | Chief Tech/Sci/R&D Officer | - | 23-05-02 |
Members of the board | Title | Age | Since |
---|---|---|---|
Stephen Simes
BRD | Director/Board Member | 72 | 22-10-12 |
Ryan Dunlap
BRD | Director/Board Member | 54 | 22-08-23 |
Karen Brunke
BRD | Director/Board Member | 72 | 22-03-31 |
1st Jan change | Capi. | |
---|---|---|
-2.63% | 102B | |
+1.62% | 96.29B | |
+2.71% | 22.18B | |
-16.67% | 21.2B | |
-8.75% | 18.31B | |
-38.74% | 17.38B | |
-13.21% | 16.36B | |
+5.41% | 13.97B | |
+33.57% | 12.17B |